z-logo
open-access-imgOpen Access
P4HB, a Novel Hypoxia Target Gene Related to Gastric Cancer Invasion and Metastasis
Author(s) -
Jun Zhang,
Shuai Guo,
Yue Wu,
Zhichao Zheng,
Yue Wang,
Yan Zhao
Publication year - 2019
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2019/9749751
Subject(s) - hypoxia (environmental) , metastasis , cancer , cancer research , medicine , gene , biology , oncology , genetics , chemistry , oxygen , organic chemistry
Gastric cancer (GC) is a common tumor-associated lethal disease, and invasiveness and metastasis are primary challenges in its clinical treatment. Hypoxia microenvironment cannot be ignored in the process of metastasis. Hypoxia inducible factor-1 α (HIF-1 α ) is the core component of the hypoxia signaling pathway. The aim of this study was to identify potential hub genes and signaling pathways associated with HIF-1 α . We explored the invasiveness- and metastasis-associated phenotype of GC via bioinformatics analysis and molecular studies. Differentially expressed genes (DEGs) were identified in GC cells and HIF-1 α -knockdown GC cells. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed, and a protein-protein interaction (PPI) network was constructed. Hub genes were identified via centrality analysis and Molecular Complex Detection (MCODE) module analysis. The findings suggested that prolyl 4-hydroxylase beta polypeptide ( P4HB ) has strong associations with HIF-1 α . Further, we observed that HIF-1 α and P4HB were upregulated in SGC-7901 and BGC-823 cells. In addition, inhibition of HIF-1 α expression reduced invasion and metastasis in GC cells; this effect was partially reversed by P4HB overexpression. Our results confirm that P4HB plays a significant role in the regulatory network of HIF-1 α . Therefore, HIF-1 α and P4HB may be considered potential biomarkers of GC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here